Cat. #151311
Anti-E2F6 [TFE61]
Cat. #: 151311
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-5 days
Target: E2F-6
Class: Monoclonal
Application: IF ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: European Institute of Oncology
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-E2F6 [TFE61]
- Research fields: Cancer;Cell biology;Genetics
- Clone: TFE61
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 38 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: IF ; IP ; WB
- Description: E2F-6 is a member of the E2F transcription factor protein family. E2F family members play a crucial role in control of the cell cycle and of the action of tumour suppressor proteins.
- Isotype: IgG1
- Myeloma used: Sp2/0-Ag14
- Recommended controls: Hela cells or K-562 nuclear extract
Target Details
- Target: E2F-6
- Molecular weight: 38 kDa
- Tissue cell line specificity: Hela cells or K-562 nuclear extract
- Target background: E2F-6 is a member of the E2F transcription factor protein family. E2F family members play a crucial role in control of the cell cycle and of the action of tumour suppressor proteins.
Applications
- Application: IF ; IP ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Furuta et al. 2010. Carcinogenesis. 31(5):766-76. PMID: 19843643.
- miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
- Kozaki et al. 2008. Cancer Res. 68(7):2094-105. PMID: 18381414.
- Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
